L. Olivatto

Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)

L. Castro, C. Ferreira, F. Meton, 2008 .

Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity.

R. Lima, J. Kligerman, E. Q. Freitas, 1994, American journal of surgery.

Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.

F. Dias, R. Lima, J. Kligerman, 1995, American journal of surgery.

Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.

L. Castro, C. Ferreira, I. Small, 2011, International journal of radiation oncology, biology, physics.

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

L. Castro, C. Ferreira, A. Victorino, 2013, Cancer.

Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

W. Miller, D. Haller, G. Bodoky, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

C. Ferreira, L. Olivatto, 2014, Cancer.